Press Release

Brian Paddick talks about his PrEP use - NAT comment

Brian Paddick talks about his PrEP use - NAT comment

Publication date

Tuesday, July 3, 2018

Lord Paddick has today spoken of his use of the HIV prevention drug PrEP in a personal story shared on the Prepster website.

In the post he tells of his enduring anxiety around HIV, stemming from the early days of the epidemic when he says he may have avoided HIV acquisition because he was “playing it straight” and married at the time.

NHS England considers expanding PrEP trial - NAT comment

NHS England considers expanding PrEP trial - NAT comment

Publication date

Friday, June 15, 2018

Deborah Gold, Chief Executive of NAT (National AIDS Trust) said: “This proposed trial expansion, from 10,000 to 13,000 participants, is essential and we urge NHS England to confirm the decision urgently.  This expansion was first proposed by NAT as necessary to estimate accurately the likely long-term needs of a routinely commissioned PrEP programme and it’s great news that this is now on the table.

Grindr's HIV data sharing - NAT comment

Grindr's HIV data sharing - NAT comment

Publication date

Wednesday, April 4, 2018

Deborah Gold, Chief Executive of NAT, said: "We are concerned to learn that Grindr has shared sensitive personal data with third parties, including apparently HIV status, email address and location. We are pleased the matter is being investigated by the Information Commissioner's Office and we look forward to their assessment of what happened. It is vitally important that individuals are told of how their personal information is going to be used and shared with third parties, for whatever reasons.